LUMO
Lumos Pharma Inc. Common Stock
$0.000+0.000 (0.000%)
Real-time Price
Price Chart
No chart data available
Key Metrics
Market Metrics
Open
$0.000
High
$0.000
Low
$0.000
Volume
N/A
Company Fundamentals
Trading Stats
Related News
BusinessWire
Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors
Aviceda Therapeutics ("Aviceda"), a private, clinical-stage biotech company focused on developing next-generation immunomodulators incorporating its proprietary High Affinity Ligands of Siglecs (HALOS™)
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.